Study guide

1.2 The Official Blueprint and Mark Allocation

MRCP UK

Track your progress as you read

Finished sections get a check mark.

1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy

1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique

2 Clinical Sciences: Cellular, Genetic & Molecular Medicine

2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders

3 Clinical Sciences: Anatomy, Physiology & Immunology

3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions

4 Clinical Sciences: Statistics, Epidemiology & Trial Design

4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification

5 Clinical Pharmacology, Therapeutics & Toxicology

5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols

6 Cardiology: Coronary Artery Disease & Heart Failure

6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation

7 Cardiology: Arrhythmias, Valvular & Pericardial Disease

7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases

8 Respiratory Medicine: Airway & Parenchymal Lung Disease

8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis

9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders

9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing

10 Gastroenterology: Luminal Gastrointestinal Disease

10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia

11 Gastroenterology: Liver, Biliary & Pancreatic Disease

11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis

12 Endocrinology & Diabetes: Diabetes & Thyroid

12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules

13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium

13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease

14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease

14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases

15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance

15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis

16 Neurology: Cerebrovascular, Headache & Demyelinating Disease

16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases

17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease

17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders

18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease

18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies

19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy

19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease

20 Infectious Diseases & Tropical Medicine

20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites

21 Haematology: Anaemias & Red Cell Disorders

21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease

22 Haematology: Malignancy, Coagulation & Transfusion Medicine

22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions

23 Psychiatry in General Medicine

23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law

24 Geriatric Medicine

24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers

25 Dermatology

25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy

26 Oncology & Palliative Medicine

26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control

27 Medical Ophthalmology

27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease

1.2 The Official Blueprint and Mark Allocation

Key Takeaways Explain This Topic AI

The Federation blueprint allocates 200 questions across 17 headings, with clinical sciences the largest at 25 questions (12.5%).

Eight specialties — cardiology, endocrinology, gastroenterology and hepatology, infectious diseases, neurology, renal, respiratory and rheumatology — carry 14 questions each, 112 marks or 56% of the exam.

Statistics, epidemiology and evidence-based medicine is worth 5 marks within clinical sciences, more than oncology, ophthalmology or palliative medicine.

Psychiatry (9), dermatology (8) and geriatric medicine (8) total 25 marks and are commonly under-revised.

The Federation states the counts indicate the likely number of questions and may vary slightly between diets.

Last updated: September 2026

The Blueprint Is a Marks Map

The Federation publishes an explicit blueprint for Part 1: a table of the likely number of questions under each broad clinical heading, updated to match the terminology of the UK Internal Medicine curriculum and in use since the 2020/1 diet. The Federation notes the figures are "an indication of the likely number of questions — the actual number may vary slightly", but they are stable enough to plan around. Revising without reference to this table is the single most common structural error in Part 1 preparation, because subjective interest rarely tracks mark weighting.

The Official Specialty Distribution

  • Specialty Questions Share of 200
  • Clinical sciences 25 12.5%
  • Clinical Pharmacology and Therapeutics 15 7.5%
  • Cardiology 14 7%
  • Endocrinology, diabetes and metabolic medicine 14 7%
  • Gastroenterology and Hepatology 14 7%
  • Infectious diseases 14 7%
  • Neurology 14 7%
  • Renal medicine 14 7%
  • Respiratory medicine 14 7%
  • Rheumatology 14 7%
  • Haematology 10 5%
  • Psychiatry 9 4.5%
  • Dermatology 8 4%
  • Geriatric medicine 8 4%
  • Oncology 5 2.5%
  • Medical ophthalmology 4 2%
  • Palliative medicine and end of life care 4 2%
  • Total 200 100%
  • Inside Clinical Sciences

Clinical sciences is the largest single heading at 25 questions, and the Federation breaks it down further:

  • Clinical science sub-area Questions
  • Cell, molecular and membrane biology 2
  • Clinical anatomy 3
  • Clinical biochemistry and metabolism 4
  • Clinical physiology 4
  • Genetics 3
  • Immunology 4
  • Statistics, epidemiology and evidence-based medicine 5
  • Total 25

Two features of this sub-table repay attention. Statistics, epidemiology and evidence-based medicine is worth 5 marks — more than oncology, more than medical ophthalmology, more than palliative medicine. It is also the most learnable block in the whole exam: sensitivity, specificity, predictive values, likelihood ratios, relative and absolute risk, number needed to treat, and the choice between parametric and non-parametric tests are a finite, formula-driven syllabus that does not change between diets. Candidates who skip it are volunteering to drop marks they could have banked.

Second, the Federation states that clinical science questions "will include a clinical stem" wherever appropriate. You are not being asked to recite the Krebs cycle; you are being asked which enzyme deficiency explains a specific patient's hypoglycaemia and hepatomegaly.

Turning the Blueprint Into a Revision Plan

Work out the marks-per-hour of each block rather than revising alphabetically.

The 40-mark foundation. Clinical sciences (25) plus clinical pharmacology and therapeutics (15) is 40 marks — 20% of the exam , and larger than any single clinical specialty. This material is also highly portable: cytochrome P450 interactions, therapeutic drug monitoring and hypersensitivity mechanisms reappear inside specialty questions.

The eight 14-mark specialties. Cardiology, endocrinology, gastroenterology and hepatology, infectious diseases, neurology, renal medicine, respiratory medicine and rheumatology carry 112 marks between them — 56% of the exam . No one of these can be sacrificed; a candidate who neglects rheumatology because it feels niche is discarding the same weight as cardiology.

The mid-weight block. Haematology (10), psychiatry (9), dermatology (8) and geriatric medicine (8) total 35 marks — 17.5% . Psychiatry and geriatrics are commonly under-revised by candidates who assume Part 1 is a "pure medicine" paper; between them they are worth more than haematology.

The small-but-cheap block. Oncology (5), medical ophthalmology (4) and palliative medicine (4) total 13 marks . Each has a small, high-yield core — oncological emergencies, the acute red eye, the WHO analgesic ladder and opioid conversion — and a few focused hours can convert most of these marks.

A Worked Prioritisation

Suppose you have 200 hours of revision. Allocating hours in proportion to marks gives roughly 25 hours to clinical sciences, 15 to pharmacology, 14 to each of the eight major specialties (112 hours), 35 across haematology, psychiatry, dermatology and geriatrics, and 13 to oncology, ophthalmology and palliative medicine. That distribution feels uncomfortable to most candidates because it forces time into psychiatry and geriatrics and caps time in a favourite specialty — which is precisely the corrective the blueprint exists to provide.

Audit your question-bank performance by blueprint heading , not by overall percentage.

A 60% score in a 14-mark specialty costs you 5.6 marks; the same 60% in medical ophthalmology costs 1.6. Fix the expensive gaps first.

Re-check the published blueprint before each diet, since the Federation updates it when the Internal Medicine curriculum changes.

Three Common Misreadings of the Blueprint

"Clinical sciences is basic science I can skip." It is 25 marks, the largest heading, and the Federation states that questions carry a clinical stem wherever appropriate. A genetics question is a pedigree with a recurrence risk; an immunology question is a patient with recurrent encapsulated organism infection.

"Rheumatology and infectious diseases are minor specialties." Both sit at 14 questions, identical to cardiology. Candidates from cardiology-heavy jobs consistently under-invest here.

"Small headings are not worth revising." Oncology, ophthalmology and palliative medicine total 13 marks against a pass standard that turns on a handful of items. The content is narrow enough that near-complete coverage is realistic in a few hours.